Why do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?

K Zimri1, A C Hesseling1, P Godfrey-Faussett2

  • 1Desmond Tutu TB Centre, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa.

Public Health Action
|September 23, 2015
PubMed

Insights

Many children do not attend specialist multidrug-resistant tuberculosis (MDR-TB) clinics due to complex social, logistical, and cultural factors. Addressing these barriers is crucial for effective pediatric MDR-TB management and treatment adherence.

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Tuberculosis research

Background:

  • Local policy mandates specialist assessment for children exposed to multidrug-resistant tuberculosis (MDR-TB).
  • A significant number of referred children do not attend these crucial specialist appointments.

Purpose of the Study:

  • To identify factors associated with non-attendance at a specialist pediatric MDR-TB clinic.
  • To understand the barriers preventing children from accessing necessary MDR-TB care.

Main Methods:

  • Focus group discussions informed questionnaire design.
  • Recruited 50 children who attended the specialist pediatric MDR-TB clinic and 50 who were referred but did not attend.
  • Compared characteristics between attending and non-attending groups.

Main Results:

  • Non-attendance was linked to Coloured ethnicity, mother being the source case, and household smoking.
  • Significant factors included travel time, cost to reach the clinic, and fear of hospital-acquired infection.
  • Median age was 35 months; 48% were boys, 4% HIV-infected, and 47% of Coloured ethnicity.

Conclusions:

  • Reasons for non-attendance are multifaceted, involving demographic, social, logistical, and cultural elements.
  • Addressing these complex barriers is essential for improving access to pediatric MDR-TB care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
465
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
741
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
423
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
795